[SYRE] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
28-Jun-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 8.65%
YoY- -226.84%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 198 168 174 625 1,362 3,644 1,399 -72.87%
PBT -18,458 -18,784 -18,443 -22,314 -24,436 -20,423 -20,281 -6.09%
Tax -36 38 -209 9 0 23 26 -
NP -18,422 -18,822 -18,234 -22,323 -24,436 -20,446 -20,307 -6.29%
Tax Rate - - - - - - - -
Total Cost 18,620 18,990 18,408 22,948 25,798 24,090 21,706 -9.72%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -9,304.04 -11,203.57 -10,479.31 -3,571.68 -1,794.13 -561.09 -1,451.54 245.45%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -4.89 -7.20 -4.84 -6.79 -9.26 -10.36 -7.72 -26.26%
EPS Diluted -4.89 -7.20 -4.84 -6.79 -9.26 -10.36 -7.72 -26.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.